Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-24-000162

Chief Accounting Officer sold 201 shares at $15.32 ($3,079)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Azoy Alexander · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-02 Sale : show line 1 in the form 10b5-1 −201 $15.32 $3,079 19,070 D
Open-market sales · 201 sh · avg $15.32 · $3,079
Loading xslF345X05/wk-form4_1733346648.xml…